238 results
8-K
EX-10.2
ksughv3t39s
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
7oix35d2do gua
1 Dec 22
Entry into a Material Definitive Agreement
9:23am
8-K
EX-99.1
zloa6gqs8yo101 4qsu
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm
8-K
EX-10.2
rmpe159l7r sk678gda
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
rt03vphq0zksfrzhn
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-99.1
z4mxgga13 dobb6frqk
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
yeky0
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
yk8qz 1sqgt
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
gw94vk
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
rlx4ggdr x41hu7e
12 Sep 22
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
7:01am
8-K
EX-99.1
lg7beayi4 2k
15 Aug 22
TherapeuticsMD Announces Second Quarter 2022 Financial Results
7:15am